At a glance
ClinicalIndex Comparison RecordN/ACompleted· 5 enrolled
Drug / intervention
HIRREM +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
High-Resolution, Relational, Resonance-Based, Electroencephalic Mirroring (HIRREM) for Stage 1 Primary Hypertension
In Brief
A clinical study evaluating HIRREM and Continued Current Care for Hypertension and 4 related conditions. Completed, enrolled 5 participants across 1 site.
Detailed Summary
The purpose of this study is to determine that effects of an intervention called High-resolution, relational, resonance-based, electroencephalic mirroring (HIRREM), on Stage 1 Primary Hypertension (systolic BP 130-139, and/or diastolic BP 80-89).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypertension, Blood Pressure, Cardiovascular Diseases, Cardiovascular Risk Factor, Autonomic Nervous System Imbalance
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedMar 2018
Enrollment StartAug 2018
Primary CompletionNov 2020
TodayJul 2026
First PostedMar 27, 2018
Enrollment StartAug 8, 2018
Primary CompletionNov 13, 2020
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 8.3 years ago
Interventions
HIRREMdevice
Technology
Continued Current Careother
Continue their current clinical care.